Sanofi, GSK say Covid vaccine shows positive result


French pharmaceuticals giant Sanofi and Britain’s GSK reported on Monday “strong immune responses” in early tests of their Covid-19 vaccine, raising hopes it could join the fight against the pandemic.

The companies said the results of the Phase 2 study will enable them to move to a late-stage trial in the coming weeks — a reversal of fortune after their research was dealt a setback late last year.

The experimental vaccine “achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult age groups in a Phase 2 study with 722 volunteers,” it said in a statement. “A global pivotal Phase 3 study is expected to start in the coming weeks.”—APP


Previous articleUS legislators question $735m arms sale to Israel
Next articleFour dead, over 42,000 affected by heavy rains, in Sri Lanka